• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Coumarans Coumarans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Coumarans

(2,3-Dihydro-1-Benzofuran-4-yl)Boronic Acid (CAS No. 1062293-35-9): A Versatile Building Block in Modern Organic Synthesis

(2,3-Dihydro-1-benzofuran-4-yl)boronic acid (CAS No. 1062293-35-9) is a highly versatile and valuable compound in the field of organic synthesis and medicinal chemistry. This boronic acid derivative, characterized by its unique 2,3-dihydrobenzofuran scaffold, has gained significant attention due to its potential applications in the synthesis of bioactive molecules and pharmaceuticals. In this article, we will delve into the chemical properties, synthetic methods, and recent advancements in the utilization of (2,3-dihydro-1-benzofuran-4-yl)boronic acid.

Chemical Structure and Properties

(2,3-Dihydro-1-benzofuran-4-yl)boronic acid is a boronic acid derivative with the molecular formula C₈H₉BO₂. The compound features a 2,3-dihydrobenzofuran ring system attached to a boronic acid moiety. The 2,3-dihydrobenzofuran ring is a six-membered ring with an oxygen atom and a double bond between the second and third carbon atoms. This structure imparts unique electronic and steric properties to the molecule, making it an attractive building block for various chemical transformations.

The boronic acid functional group is known for its reactivity in Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of biologically active compounds and pharmaceuticals. The presence of this functional group in (2,3-dihydro-1-benzofuran-4-yl)boronic acid allows for efficient and selective coupling with aryl halides and vinyl halides, leading to the formation of complex molecular architectures.

Synthetic Methods

The synthesis of (2,3-dihydro-1-benzofuran-4-yl)boronic acid has been extensively studied and optimized over the years. One of the most common methods involves the conversion of 4-bromodihydrobenzofuran to the corresponding boronic acid using a palladium-catalyzed borylation reaction. This process typically involves the use of bis(pinacolato)diboron (B₂PIN₂) as the boron source and a palladium catalyst such as Pd(dppf)Cl₂. The reaction is carried out under an inert atmosphere at elevated temperatures to ensure high yields and selectivity.

An alternative approach involves the direct borylation of 4-hydroxydihydrobenzofuran using a transition metal catalyst. This method offers a more straightforward route to the target compound but may require careful optimization of reaction conditions to achieve satisfactory yields.

Applications in Medicinal Chemistry

(2,3-Dihydro-1-benzofuran-4-yl)boronic acid has found extensive applications in medicinal chemistry due to its ability to serve as a versatile building block for the synthesis of bioactive molecules. One notable application is in the development of inhibitors for various therapeutic targets. For example, compounds derived from (2,3-dihydro-1-benzofuran-4-yl)boronic acid have shown promise as inhibitors of protein kinases, which are key enzymes involved in cellular signaling pathways and are often dysregulated in diseases such as cancer.

A recent study published in the Journal of Medicinal Chemistry reported the synthesis and biological evaluation of a series of compounds based on (2,3-dihydro-1-benzofuran-4-yl)boronic acid. These compounds exhibited potent inhibitory activity against specific protein kinases and demonstrated promising antiproliferative effects in cancer cell lines. The study highlighted the potential of this scaffold as a lead structure for further drug development.

In addition to kinase inhibitors, (2,3-dihydro-1-benzofuran-4-yl)boronic acid-based compounds have also been explored for their potential as anti-inflammatory agents. Research has shown that these compounds can effectively modulate inflammatory responses by targeting key signaling pathways involved in inflammation. This makes them attractive candidates for the treatment of inflammatory diseases such as arthritis and asthma.

Recent Advances and Future Perspectives

The field of organic synthesis continues to evolve rapidly, driven by advances in catalysis and computational methods. Recent developments have led to more efficient and environmentally friendly synthetic routes for preparing (2,3-dihydro-1-benzofuran-4-yl)boronic acid. For example, photocatalytic methods have been explored as an alternative to traditional palladium-catalyzed borylation reactions. These methods offer several advantages, including milder reaction conditions and reduced use of toxic reagents.

In terms of applications, there is growing interest in using (2,3-dihydro-1-benzofuran-4-yl)boronic acid-based compounds for targeted drug delivery systems. The unique properties of this scaffold make it well-suited for conjugation with targeting ligands or other functional groups that can enhance drug efficacy and reduce side effects. Ongoing research is focused on optimizing these conjugates for specific therapeutic applications.

In conclusion, (2,3-dihydro-1-benzofuran-4-yl)boronic acid (CAS No. 1062293-35-9) is a highly valuable compound with diverse applications in organic synthesis and medicinal chemistry. Its unique chemical structure and reactivity make it an attractive building block for the development of novel bioactive molecules and pharmaceuticals. As research continues to advance, we can expect to see even more innovative uses for this versatile compound in the future.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)